The Clinical Problem Solvers
APRIL 24, 2025
They explore the impact of racism, trauma, and inequities in care, while emphasizing the need for culturally grounded, community-based prevention. Community-Based Prevention: The conversation then moves toward community-based prevention, with Dr. Simon advocating for trusted community networks to support youth mental health.
FDA Law Blog
FEBRUARY 19, 2023
Houck was a diversion investigator with the Drug Enforcement Administration (“DEA”) in the field and at agency headquarters for 15 years before joining HPM in 2001. The session will occur Friday, March 24th. Pharmacists can earn 1 continuing practice education credit for attending this session.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
MAY 30, 2022
Kozhimannil—the Distinguished McKnight University Professor in the Division of Health Policy and Management at the University of Minnesota and Director of the Rural Health Research Center. The exact statistics vary by location and by the overall level of investment in services such as childcare and parental leave within each community.
GeriPal
MARCH 24, 2023
Usually I don’t put a lot of background on this podcast, but I got to … in November of 2022, Ava Kofman, along with ProPublica, published … well I won’t want to say great, published an article in The New Yorker that I think it was divisive in the hospice and palliative care community. Management, it’s hard.
FDA Law Blog
FEBRUARY 11, 2024
Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. The letter is signed by six former DEA administrators and five former Directors of National Drug Policy. The earliest tenured is John Bartels, who served as Administrator from 1973 to 1975.
Expert insights. Personalized for you.
52 
Let's personalize your content